ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)

Technical Analysis Report for USA stock CRSP Crispr Therapeutics. Dated: 17 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics

Crispr Therapeutics Opened at 48.81 and Closed at: 47.79, which is -1.61% of previous session's close. It moved within a range of 47.09 and 48.81
The session was a Bearish session with an average volume of 1067814, which is -28.53% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.
  • The stock has fallen, and its long term trend is also negative and in a downtrend.

A Dead cross was found 1 days back on short term averages

Support for tomorrow is 46.58 and resistance for tomorrow is 48.3
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 46.98, 46.18 resistance for tomorrow's hourly charts is 48.7, 49.62

10 Day SMA for Crispr Therapeutics (CRSP) is 54.05 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Crispr Therapeutics (CRSP) is 54.6 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Crispr Therapeutics (CRSP) is 53.05 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 52.83 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Crispr Therapeutics is 55.24 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Crispr Therapeutics is at 54.6 and 200 DMA is at 55.24, while 50 DMA and 100 DMA are at 53.05 and 52.83 respectively

Crispr Therapeutics (CRSP) moving average of 20 SMA is at 54.6 and 20 EMA is at 53.29

Crispr Therapeutics (CRSP) moving average of 50 SMA is at 53.05 and 50 EMA is at 53.3

Crispr Therapeutics (CRSP) moving average of 100 SMA is at 52.83 and 100 EMA is at 53.28

Crispr Therapeutics (CRSP) moving average of 200 SMA is at 55.24 and 200 EMA is at 52.77

Cvs Health has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Cvs Health, about 20.98% more returns!

United Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in United Therapeutics, about 11.48% more returns!

Crispr Therapeutics has performed better than Sintx Technologies in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Redhill Biopharma in short term. Holding Crispr Therapeutics could be a better choice for now!

Outlook Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Outlook Therapeutics, about 0.82% more returns!

Endra Life has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Endra Life, about 16.48% more returns!

Moderna Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Moderna Inc, about 8.09% more returns!

Marker Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Marker Therapeutics, about 10.15% more returns!

Grifols S has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Grifols S, about 9.89% more returns!

Eyegate Pharmaceuticals has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 10.6% more returns!

Cue Biopharma has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Cue Biopharma, about 21.14% more returns!

Crispr Therapeutics has performed better than Bioxcel Therapeutics in short term. Holding Crispr Therapeutics could be a better choice for now!

Allogene Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 1.15% more returns!

Aclaris Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 37.87% more returns!

Crispr Therapeutics Technical analysis of indicators

Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Crispr Therapeutics in short term and the sell signal is strong.

Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Crispr Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 54 and Crispr Therapeutics CRSP stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.

Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CRSP Experts View which covers a lot of information including buying and selling signals

CRSP future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here

Chart Crispr Therapeutics (CRSP)  Technical (Analysis) Reports Crispr Therapeutics [

Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Crispr Therapeutics (CRSP)  Technical (Analysis) Reports Crispr Therapeutics [

 

Back to top